Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income and comprehensive income	$ 147,579	$ 63,615
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	130,038	120,726
Amortization of debt discount and issuance costs	851	11,882
Non-cash employee stock compensation expense	8,283	5,510
Fair value changes in equity securities	4,972	3,318
Deferred tax benefit	(37,117)	(5,329)
Other	(148)
Changes in assets and liabilities:
Royalty receivables	(11,589)	(1,198)
Stream inventory	(567)	(3,102)
Income tax receivable	(8,658)	(8,750)
Prepaid expenses and other assets	(5,771)	2,474
Accounts payable	(1,295)	(4,326)
Income tax payable	14,054	(2,002)
Uncertain tax positions	(132)	3,130
Other liabilities	8,695	(5,039)
Net cash provided by operating activities	249,195	180,909
Cash flows from investing activities:
Acquisition of stream and royalty interests	(107,855)	(1,055)
Purchase of equity securities	(461)	(3,573)
Other	3,227	(157)
Net cash used in investing activities	(105,089)	(4,785)
Cash flows from financing activities:
Repayment of debt	(115,000)
Net payments from issuance of common stock	(4,257)	(1,982)
Common stock dividends	(53,111)	(50,114)
Contributions from non-controlling interest	3,300	3,210
Other	(798)	8
Net cash used in financing activities	(169,866)	(48,878)
Net (decrease) increase in cash and equivalents	(25,760)	127,246
Cash and equivalents at beginning of period	119,475	88,750
Cash and equivalents at end of period	$ 93,715	$ 215,996